Company Filing History:
Years Active: 2021-2024
Title: Jamsheed Ghadiri: Innovator in Nucleotide Reagent Solutions
Introduction
Jamsheed Ghadiri is a notable inventor based in Palo Alto, California, recognized for his contributions to the field of biochemistry and sequencing methodologies. With a total of three patents to his name, he has made significant strides in improving nucleotide reagent solutions, critical for various applications in molecular biology.
Latest Patents
Among his latest inventions, Ghadiri has developed innovative sequencing methods that utilize improved nucleotide reagent solutions. One of these patents describes a reagent solution comprising water, a nucleotide, and tris(2-carboxyethyl)phosphine, formulated within a concentration range of 0.5 µM to 1000 µM. This reagent solution can be further enhanced with a non-ionic surfactant or a biocidal agent, both available in concentrations from 0.001% to 1%. Additionally, it may incorporate salts like sodium chloride or magnesium sulfate, contributing to its efficacy in various laboratory protocols.
Another notable patent also revolves around the development of nucleotide reagent solutions, reiterating the importance of tris(2-carboxyethyl)phosphine and similar components, showcasing his consistent focus on advancing nucleotide chemistry in scientific research.
Career Highlights
Ghadiri is associated with Life Technologies Corporation, a prominent company that specializes in providing innovative solutions for the life sciences sector. His work and patents reflect a keen understanding of biochemistry and its applications in research and diagnostics, paving the way for new approaches in the field.
Collaborations
Collaboration is key to innovation, and Ghadiri has worked alongside noteworthy colleagues, including Karta Atehortua-Khalsa and David Marran. Their collective efforts contribute to the advancement of research and product development in the life sciences.
Conclusion
In summary, Jamsheed Ghadiri stands out as a prolific inventor in the realm of nucleotide reagents, with patents that enhance the capabilities of researchers in molecular biology. His continued work at Life Technologies Corporation promises further advancements and innovative solutions in the field.